FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2183455205> ?p ?o ?g. }

• W2183455205 endingPage "25" @default.
• W2183455205 startingPage "17" @default.
• W2183455205 abstract "Since its introduction in 1981, peritoneal dialysis (PD) has become firmly established as an effective mode of renal replacement therapy and serves an increasing patient population in Korea. The latest registry data indicate that about 3700 end-stage renal disease patients are maintained on chronic PD, representing 24.1% of the country's dialysis population. The majority (93.3%) of these patients are on continuous ambulatory peritoneal dialysis (CAPD) using the two-bag disconnect system, while only 3.3% are on automated PD. Under current renal reimbursement policies, most dialysis patients have to pay 20% of dialysis fees. Thus CAPD patients on 4 x 2-L daily exchanges pay about US$200 per month, not including medication and travel costs. Traditionally, most PD centers in Korea have used the “standard” prescription of 4 exchanges of 2 L of solution for most of their patients. A recent survey of 1467 patients who commenced CAPD in 1997 revealed that 84% of these patients were initially prescribed 4 x 2-L exchanges, while 12% were given a daily volume of 6 L. With this standard prescription, the percentages of Korean CAPD patients initially achieving the adequacy target of Kt/V urea ≥ 2.0 and standardized creatinine clearance (SCCr) ≥ 60 L/week/ 1.73 m 2 , were 74.4% and 82.1%, respectively. It is likely that, among current Korean CAPD patients, a much lower percentage will achieve the clearance targets compared to this initial outcome, but the precise data are not available. However, it is not clear whether the levels of small-solute clearance recommended for optimal PD outcomes, and proposed by the NKF-DOQI guidelines, will bring the expected benefits to Korean patients. Overall survival of Korean PD patients appears to be as good as, or even better than, that in most other countries. Recently, a single large PD center reported patient survival of 92.1%, 85.6%, 81.4%, and 67.6% at 1, 2, 3, and 5 years respectively. Other centers also reported similar outcomes. As in other countries, cardiovascular deaths predominate among Korean patients: death was due to cardiac causes in 29%, to vascular causes in 21%, and to infectious causes in 24%. Peritonitis is the most important barrier to prolonged use of CAPD in Korea, and more PD patients transfer to hemodialysis because of peritonitis than in other countries. To further reduce the morbidity and mortality of Korean PD patients, various control measures need to be implemented that can reduce or prevent peritonitis and other infectious complications. Also, to further improve long-term patient outcome, Korean nephrologists need to establish and practice optimal clearance targets in the chronic care of these patients." @default.
• W2183455205 created "2016-06-24" @default.
• W2183455205 creator A5003792129 @default.
• W2183455205 creator A5007499031 @default.
• W2183455205 creator A5026449106 @default.
• W2183455205 creator A5036109427 @default.
• W2183455205 creator A5044459999 @default.
• W2183455205 creator A5044548117 @default.
• W2183455205 creator A5050124786 @default.
• W2183455205 creator A5054868835 @default.
• W2183455205 creator A5058413853 @default.
• W2183455205 creator A5088071825 @default.
• W2183455205 creator A5090993372 @default.
• W2183455205 date "1999-06-01" @default.
• W2183455205 modified "2023-10-14" @default.
• W2183455205 title "Current Status of Peritoneal Dialysis in Korea: Efforts to Achieve Optimal Outcome" @default.
• W2183455205 cites W1844228453 @default.
• W2183455205 cites W1978129060 @default.
• W2183455205 cites W2011769683 @default.
• W2183455205 cites W2017914031 @default.
• W2183455205 cites W2050586165 @default.
• W2183455205 cites W2064111641 @default.
• W2183455205 cites W2067609916 @default.
• W2183455205 cites W2086486529 @default.
• W2183455205 cites W2090994364 @default.
• W2183455205 cites W2127298405 @default.
• W2183455205 cites W2132199691 @default.
• W2183455205 cites W2341858843 @default.
• W2183455205 cites W2410085699 @default.
• W2183455205 cites W2419284332 @default.
• W2183455205 cites W4247429830 @default.
• W2183455205 cites W4256261226 @default.
• W2183455205 cites W53790794 @default.
• W2183455205 doi "https://doi.org/10.1177/089686089901903s04" @default.
• W2183455205 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10433548" @default.
• W2183455205 hasPublicationYear "1999" @default.
• W2183455205 type Work @default.
• W2183455205 sameAs 2183455205 @default.
• W2183455205 citedByCount "24" @default.
• W2183455205 countsByYear W21834552052013 @default.
• W2183455205 countsByYear W21834552052017 @default.
• W2183455205 crossrefType "journal-article" @default.
• W2183455205 hasAuthorship W2183455205A5003792129 @default.
• W2183455205 hasAuthorship W2183455205A5007499031 @default.
• W2183455205 hasAuthorship W2183455205A5026449106 @default.
• W2183455205 hasAuthorship W2183455205A5036109427 @default.
• W2183455205 hasAuthorship W2183455205A5044459999 @default.
• W2183455205 hasAuthorship W2183455205A5044548117 @default.
• W2183455205 hasAuthorship W2183455205A5050124786 @default.
• W2183455205 hasAuthorship W2183455205A5054868835 @default.
• W2183455205 hasAuthorship W2183455205A5058413853 @default.
• W2183455205 hasAuthorship W2183455205A5088071825 @default.
• W2183455205 hasAuthorship W2183455205A5090993372 @default.
• W2183455205 hasConcept C126322002 @default.
• W2183455205 hasConcept C141071460 @default.
• W2183455205 hasConcept C160735492 @default.
• W2183455205 hasConcept C162324750 @default.
• W2183455205 hasConcept C177713679 @default.
• W2183455205 hasConcept C2426938 @default.
• W2183455205 hasConcept C2779056158 @default.
• W2183455205 hasConcept C2779541074 @default.
• W2183455205 hasConcept C2779703844 @default.
• W2183455205 hasConcept C2779978075 @default.
• W2183455205 hasConcept C2908647359 @default.
• W2183455205 hasConcept C2909406889 @default.
• W2183455205 hasConcept C50522688 @default.
• W2183455205 hasConcept C71924100 @default.
• W2183455205 hasConcept C98274493 @default.
• W2183455205 hasConcept C99454951 @default.
• W2183455205 hasConceptScore W2183455205C126322002 @default.
• W2183455205 hasConceptScore W2183455205C141071460 @default.
• W2183455205 hasConceptScore W2183455205C160735492 @default.
• W2183455205 hasConceptScore W2183455205C162324750 @default.
• W2183455205 hasConceptScore W2183455205C177713679 @default.
• W2183455205 hasConceptScore W2183455205C2426938 @default.
• W2183455205 hasConceptScore W2183455205C2779056158 @default.
• W2183455205 hasConceptScore W2183455205C2779541074 @default.
• W2183455205 hasConceptScore W2183455205C2779703844 @default.
• W2183455205 hasConceptScore W2183455205C2779978075 @default.
• W2183455205 hasConceptScore W2183455205C2908647359 @default.
• W2183455205 hasConceptScore W2183455205C2909406889 @default.
• W2183455205 hasConceptScore W2183455205C50522688 @default.
• W2183455205 hasConceptScore W2183455205C71924100 @default.
• W2183455205 hasConceptScore W2183455205C98274493 @default.
• W2183455205 hasConceptScore W2183455205C99454951 @default.
• W2183455205 hasIssue "3_suppl" @default.
• W2183455205 hasLocation W21834552051 @default.
• W2183455205 hasLocation W21834552052 @default.
• W2183455205 hasOpenAccess W2183455205 @default.
• W2183455205 hasPrimaryLocation W21834552051 @default.
• W2183455205 hasRelatedWork W1536778544 @default.
• W2183455205 hasRelatedWork W1575710087 @default.
• W2183455205 hasRelatedWork W2091699874 @default.
• W2183455205 hasRelatedWork W2149379724 @default.
• W2183455205 hasRelatedWork W2407628641 @default.
• W2183455205 hasRelatedWork W2472460999 @default.
• W2183455205 hasRelatedWork W2729657265 @default.
• W2183455205 hasRelatedWork W41875096 @default.

• next